Does CTLA-4 inhibit T-cell activation and prevent prolonged immune responses?

CTLA-4 (Cytotoxic T-Lymphocyte Associated Protein 4) is a critical negative regulator of the immune system, essential for maintaining homeostasis and preventing the runaway activation of T cells.

Mechanisms of T-cell inhibition

CTLA-4 exerts its inhibitory effects through a multi-layered molecular strategy that targets the co-stimulatory signals necessary for T-cell activation:

• Competitive Inhibition: CTLA-4 acts as a high-affinity decoy for the B7 ligands (CD80/B7-1 and CD86/B7-2) on antigen-presenting cells (APCs). It binds CD80 with a dissociation constant (Kd) of approximately 0.42 µM, outcompeting the stimulatory receptor CD28, which has a much lower affinity (Kd ~4 µM). By sequestering these ligands, CTLA-4 prevents CD28 from delivering the "second signal" required for T-cell proliferation.
• Ligand Depletion (Trans-endocytosis): Beyond mere competition, CTLA-4 actively removes CD80 and CD86 from the surface of APCs through a process called trans-endocytosis. Once captured, these ligands are internalized and degraded, effectively depleting the costimulatory potential of the APC for other T cells.
• Intracellular Signaling: CTLA-4 initiates direct inhibitory signaling by recruiting phosphatases such as SHP-2 to its cytoplasmic tail. These phosphatases dephosphorylate signaling molecules associated with the T-cell receptor (TCR) complex, leading to reduced interleukin-2 (IL-2) production and arresting the cell cycle in the G1 phase.

Limiting prolonged immune responses

The physiological role of CTLA-4 is to terminate immune responses once the initial stimulus is resolved.

• Immune Resolution: Without the dampening effect of CTLA-4, effector T cells fail to enter a quiescent state, leading to persistent inflammation and tissue damage.
• Systemic Consequences of Deficiency: The necessity of this "off switch" is evidenced by CTLA-4 knockout models, which develop fatal, early-onset multiorgan lymphoproliferative disease. In humans, CTLA-4 haploinsufficiency causes severe immune dysregulation and chronic organ infiltration, demonstrating that CTLA-4 is indispensable for preventing indefinite immune activation.

Bottom line

The claim is fully supported; CTLA-4 is a primary inhibitory checkpoint that prevents excessive T-cell activation and ensures the resolution of immune responses, thereby protecting against systemic autoimmunity and chronic inflammation.